Results 151 to 160 of about 25,087 (209)

Molecularly targeted therapy and immunotherapy in leukemias. [PDF]

J Hematol Oncol
Cousin E, Picard A, Oundjian M, Tardif N, Quemener A, Rio AG, Galibert MD, Gandemer V, Mazurier F.   +8 more
europepmc   +1 more source

Current Knowledge of the Integrated Stress Response in the Development and Management of Acute Myeloid Leukemia: A Novel Target with Encouraging Progress. [PDF]

Drug Des Devel Ther
Jiang W, Hong Y, Wang P, Yang X, Shao K, Li M, Wu D.   +6 more
europepmc   +1 more source

Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL [PDF]

, 2018
Bartlett, Nancy L.
core   +1 more source

Targeting relapsed/refractory and MRD + Ph + ALL: olverembatinib-venetoclax bridging enhances allo-HSCT outcome​. [PDF]

Ann Hematol
Zhang X, Zhao Y, Zhai W, Ma Q, Cao Y, Wei J, Liang C, Chen X, Cao W, Yang D, Pang A, He Y, Feng S, Han M, Zhang R, Jiang E.   +15 more
europepmc   +1 more source

Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study. [PDF]

J Clin Oncol
Popat R, Beksac M, Dimopoulos MA, Gatt ME, Gay F, Jo JC, Kapoor P, Katodritou E, Kortüm KM, Ling S, Nagarajan C, Suzuki K, Qiu L, Onishi M, Ku G, Dail M, Mukherjee N, Ross JA, Badawi MA, Fusco MJ, Dobkowska E, Arriola E, Bueno OF, Bahlis NJ, Iida S, Moreau P, Valent J, Mateos MV.   +27 more
europepmc   +1 more source

BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B-Cell and Immune Disorders. [PDF]

Biomolecules
Duminuco A, De Luca P, Stanzione G, Caruso LA, Lavenia G, Scarso S, Garibaldi B, Palumbo FE, Vetro C, Palumbo GA.   +9 more
europepmc   +1 more source

Harnessing Venetoclax in NPM1-Mutated AML: A Path to Sustained Remission and Beyond. [PDF]

Cancers (Basel)
Molica M, Simio C, De Fazio L, Alati C, Martino M, Rossi M.   +5 more
europepmc   +1 more source

Combining drugs that bypass p53 to treat TP53-mutated leukemias. [PDF]

Blood Adv
Biswas S, Zahran ZAM, Gu X, Cardone L, Marti R, Mouannes N, Stich M, Jain A, Fedorov K, Tomlinson B, Goldfinger M, Verma A, Saunthararajah Y.   +12 more
europepmc   +1 more source

Nanomechanical and Thermodynamic Alterations of Red Blood Cells in Chronic Lymphocytic Leukemia: Implications for Disease and Treatment Monitoring. [PDF]

Int J Mol Sci
Strijkova V, Katrova V, Ivanova M, Langari A, Gartcheva L, Guenova M, Alexandrova-Watanabe A, Taneva SG, Krumova S, Todinova S.   +9 more
europepmc   +1 more source